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Introduction {#sec1}
============

Human embryonic stem cells (hESCs) are derived from the inner cell mass (ICM) of blastocysts at the preimplantation stage ([@bib48]). Initially, hESCs were thought to be similar to ICM cells, such as mouse ESCs (mESCs), which are derived from the ICMs of mouse blastocysts ([@bib8]). However, significant differences have been observed between hESCs and mESCs; for example, maintenance of the hESC undifferentiated state depends on fibroblast growth factor 2 (FGF2) and the transforming growth factor β (TGF-β) family ([@bib49]) but does not require leukemia inhibitory factor (LIF). In mESCs, dual inhibition of the glycogen synthase kinase 3 (GSK3) and the mitogen-activated protein kinase (MAPK)-extracellular signal-regulated kinase (ERK) pathways (termed 2i) ([@bib56]) together with LIF induces mESCs into a state more closely resembling ICM cells ([@bib1], [@bib23]). These mESCs are considered to be in a "ground" or "naive" state. In parallel with these studies, a pluripotent state of epiblast stem cells (mEpiSCs) established from post-implantation mouse embryos ([@bib2], [@bib45]) is designated as a "primed" state, which shares many common features with hESCs. Importantly, they can be converted into the naive state by reprogramming factors, including Oct3/4 (also known as Pou5f1), Nanog, Prdm14, Klf2, Klf4, Esrrb, Nr5a1, and Nr5a2, under the 2i/LIF condition ([@bib9], [@bib11], [@bib16], [@bib17], [@bib19], [@bib41]). Efforts to induce a naive state of human pluripotency identified OCT3/4, KLF2, and KLF4 as important inducing factors ([@bib18]). It was also shown that simultaneous expression of NANOG and KLF2 can generate two kinds of naive cells, termed 5i/L/A and reset cells, that are considered closer to *in vivo* peri-implantation pluripotent cells in some aspects than other established naive-like cells ([@bib3], [@bib4], [@bib10], [@bib28], [@bib36], [@bib44], [@bib47], [@bib52]). Comparison analyses of the cell lines unveiled significant differences between primed and naive cells in terms of cellular responses to 2i conditions, metabolism, transcriptional and epigenetic profiles, and X chromosome status. Such findings provide criteria for the definitions of human naive pluripotency, but the molecular mechanisms regulating induction of the naive state from the primed state remain unclear. In this study, we examine the effects of various transcription factors on naive state induction in hPSCs.

Results {#sec2}
=======

NR5A1 Overexpression Induces Naive-Associated Gene Expression in Primed hPSCs {#sec2.1}
-----------------------------------------------------------------------------

To understand the molecular mechanisms controlling naive conversion in hPSCs, we examined whether exogenous expression of various transcription factors could promote expression of the naive-associated genes *NANOG* and *KLF4* ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). We selected ten genes that are either known inducers of mouse naive pluripotency or play important roles in mouse pluripotency ([@bib9], [@bib11], [@bib16], [@bib17], [@bib19], [@bib29], [@bib32], [@bib41]). A lentiviral system was used to transfect each gene into the hESC line H9, which was cultured under feeder-free conditions with mouse embryonic fibroblast (MEF)-conditioned medium to maintain a primed state ([Figure S1](#mmc1){ref-type="supplementary-material"}A). The MEF-conditioned medium was used for initial screening because we routinely cultivate hESCs on MEFs with KnockOut Serum Replacement-based medium whose components are similar to those of the MEF-conditioned medium. Real-time PCR analysis revealed that expression of both *NANOG* and *KLF4* was upregulated by NR5A1 overexpression ([Figure S1](#mmc1){ref-type="supplementary-material"}B). This result was unexpected as NR5A1 overexpression in mEpiSCs does not induce expression of naive-associated genes under primed conditions ([@bib13]), prompting us to further investigate the ability of NR5A1 as an inducer of human naive pluripotency.

To facilitate our analyses, we established a doxycycline (DOX)-inducible expression system for NR5A1 ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D). An NR5A2 expression system was generated in parallel because of its high sequence similarity with NR5A1. DOX activated transgene expression in transfectants carrying NR5A1 or NR5A2 (referred to as N1 and N2 cells unless specified otherwise) cultured in mTeSR1 (referred to as the TGF-β and FGF2 \[TF\] condition for primed cells; [Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F). Because the MEF-conditioned medium used for initial screening contains undefined factors from feeder cells, which hampers detailed molecular analysis, we used the defined medium mTeSR1 instead. Naive-associated genes, such as *PRDM14* and *TFCP2L1* ([@bib7], [@bib44], [@bib47]) as well as *NANOG* and *KLF4* were upregulated at the mRNA and protein levels in the transfectants compared with parental cells cultured with DOX (referred to as parental cells unless specified otherwise; [Figures 1](#fig1){ref-type="fig"}A and 1B). We next investigated whether NR5A transfectants can survive after single-cell dissociation, because, unlike cells in the primed state, naive-state hESCs are resistant to cell death caused by dissociation. Flow cytometric analysis revealed a dramatic reduction in the proportion of annexin V-positive cells (indicating dying or dead cells) in NR5A transfectants compared with parental cells 12 h after dissociation ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}G). Both N1 and N2 cells were maintained by single-cell passaging for over ten passages with sustained expression of OCT3/4, NANOG, and SOX2 ([Figures 1](#fig1){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}H). However, the growth rates of both transfectants were decreased compared with parental cells ([Figure 1](#fig1){ref-type="fig"}E). Cell-cycle analysis revealed an increased G0/1 phase population and a decreased S phase population ([Figure 1](#fig1){ref-type="fig"}F). These results suggest that NR5A-induced cells lost a subset of the features of primed pluripotency. The changes in gene expression and tolerance to single-cell passaging were no longer apparent by day 10 after DOX withdrawal, indicating their dependence on NR5A expression ([Figures S1](#mmc1){ref-type="supplementary-material"}I--S1K).Figure 1Overexpression of NR5A Receptors Induces Naive-Associated Gene Expression in hPSCs(A and B) Expression of genes associated with the naive pluripotent state. Data from parental (P), NR5A1-expressing (N1), and NR5A2-expressing (N2) cells were analyzed by the comparative ΔCt method. DOX-treated and untreated (A, top and bottom, respectively) samples are shown. In (A), expression in parental cells under each condition was set to 1. β-Actin was used as an internal control. P (−) represents parental cells cultured without DOX.(C) Percentages of annexin V-positive cells before (0 h) and 12 h after single-cell dissociation. ^∗∗∗^p \< 0.001 versus parental cells at 0 or 12 h (Dunnett\'s test).(D) Representative images of parental cells and NR5A transfectants in the presence or absence of DOX at day 3 after single-cell dissociation. Scale bar, 100 μm.(E) Growth rates of parental cells and NR5A transfectants. Cells were counted every 24 h. Parental cells were treated with Y-27632 for the first 24 h of culture.(F) Cell proliferation analysis by Click-iT 5-ethynyl-2′-deoxyuridine (EdU) assay. After EdU treatment for 1 h, the cells were co-stained with FxCycle Violet and analyzed by flow cytometry.Data are represented as mean ± SD (A and E) or SEM (C and F) of three biological replicates. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus parental cells (Dunnett\'s test). See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

NR5A1-Induced Cells Are Stably Maintained in Culture with GSK3 Inhibition {#sec2.2}
-------------------------------------------------------------------------

NR5A-induced cells displayed a cell proliferation defect in the primed (TF) condition, suggesting that the naive (2i/LIF) condition is more suitable for cell growth while sustaining pluripotency. We investigated whether N1 and N2 cells can be maintained in the presence of the mitogen-activated protein kinase (MEK)-ERK inhibitor PD0325901 (PD03), the GSK3 inhibitor CHIR99021 (CHIR), both inhibitors (2i), or 2i/LIF in custom mTeSR1 lacking TGF-β and FGF2, which are not required for maintaining cells in the naive state. Under 2i and 2i/LIF conditions, parental cells differentiated soon after culturing, whereas all transfectants were stably maintained over ten passages by single-cell passaging with sustained expression of OCT3/4, NANOG, and SOX2 ([Figures 2](#fig2){ref-type="fig"}A, 2B, [S2](#mmc1){ref-type="supplementary-material"}A, and S2B). Interestingly, NR5A transfectants also maintained their pluripotency with PD03 or CHIR alone, with sustained expression of *NANOG* and *KLF4* ([Figure 2](#fig2){ref-type="fig"}C). However, when we examined naive pluripotency marker expression, including *DPPA3* and *ZFP42* ([@bib44], [@bib47]), N1 cells treated with CHIR alone (N1-CHIR cells) had significantly increased expression of *DPPA3*, but not *ZFP42* ([Figure 2](#fig2){ref-type="fig"}D). N1-CHIR cells were maintained as packed colonies, similar to the 2i and 2i/LIF conditions ([Figure 2](#fig2){ref-type="fig"}A), and expressed NANOG and KLF4 ([Figure 2](#fig2){ref-type="fig"}E). Both N1- and N2-CHIR cells formed teratomas containing the three germ layers of ectoderm, mesoderm, and endoderm when transplanted into immunodeficient mice ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Furthermore, the CHIR condition increased cell proliferation and enhanced entry into S phase of the cell cycle ([Figures 2](#fig2){ref-type="fig"}F and 2G). In contrast, PD03 had little or no effect, and LIF also had little effect. These results suggested that CHIR treatment alone was sufficient to maintain pluripotency and facilitate the proliferation of NR5A-induced cells.Figure 2NR5A1-Induced Cells Are Stably Maintained in Culture with a GSK3 Inhibitor(A) Representative images of parental at day 4 and N1 cells at passage 10 after culturing with combined GSK3 and MEK-ERK inhibition.(B) Flow cytometric analysis of pluripotency markers in parental and N1 cells at passage 10 cultured under each condition.(C and D) Expression of the indicated genes in N1 cells. RNA was extracted from cells cultured for \>10 passages under each condition. Data were analyzed by the comparative ΔCt method. The TF condition was set to 1.(E) Immunocytochemical staining of pluripotency markers and FLAG in parental and CHIR-treated N1 (N1-CHIR) cells at passage 6.(F) Growth rates of N1 cells. Cells after switching from TF to each condition were counted every 24 h. Parental cell data from [Figure 1](#fig1){ref-type="fig"}E are shown here for comparison.(G) Cell proliferation analysis of N1 cells cultured for \>3 passages under inhibitor conditions by EdU assay.(H) Phosphorylated MEK1/2 and ERK1/2 in parental and N1 cells. The cells were transferred from the TF condition (mTeSR1) to custom mTeSR1 lacking TGF-β and FGF2. After 23 h of treatment, inhibitors were added to each culture for 1 h. Under TF conditions, custom mTeSR1 was changed to the TF condition. Under (−) conditions, the cells were treated with DMSO. β-Actin was used as a loading control.Scale bars, 100 μm. Data are represented as mean ± SD (C, D, and F) or SEM (G) of three biological replicates. ^∗^p \< 0.05; ^∗∗^p \< 0.01 versus TF condition (C, D, and G) or versus parental cells (F); Dunnett\'s test. See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

In line with the result under the TF condition ([Figures S1](#mmc1){ref-type="supplementary-material"}I--S1K), we confirmed that the pluripotency of N1-CHIR cells was dependent on NR5A1 expression, because DOX withdrawal induced differentiation even under the CHIR condition ([Figure S2](#mmc1){ref-type="supplementary-material"}D). To ensure that the cellular response to CHIR was independent of the hPSC lines used, we established N1- or N2-CHIR cells derived from the hESC line KhES-1 and the human induced pluripotent stem cell (hiPSC) line 253G1, in which we constitutively overexpressed the NR5A receptors ([Figure S2](#mmc1){ref-type="supplementary-material"}E). Transgene expression significantly reduced the proportions of annexin V-positive cells ([Figure S2](#mmc1){ref-type="supplementary-material"}F), and the transfectants maintained their pluripotency for more than ten passages, except for N2-CHIR cells derived from KhES1 cells, which displayed \>40% differentiation ([Figure S2](#mmc1){ref-type="supplementary-material"}G). This result may reflect the lower NANOG, KLF4, and TFCP2L1 expression in N2-CHIR cells compared with N1-CHIR cells ([Figures S2](#mmc1){ref-type="supplementary-material"}H and S2I), suggesting that NR5A2 is a weaker inducer of naive pluripotency than NR5A1.

In primed cells, suppression of MEK-ERK signaling by PD03 decreased *OCT3/4* and *NANOG* expression soon after treatment ([Figure S2](#mmc1){ref-type="supplementary-material"}J). In naive cells, reactivation of MEK-ERK signaling by PD03 withdrawal induces downregulation of *NANOG* and *KLF4* ([@bib47]). Conversely, our results revealed that the presence or absence of PD03 had little impact on pluripotency in NR5A-induced cells. To understand this, we investigated whether PD03 suppressed ERK1/2 phosphorylation by MEK ([Figure 2](#fig2){ref-type="fig"}H). Phosphorylated ERK1/2 was not detected in PD03-treated control or N1 cells, indicating that PD03 acted as expected. PD03 treatment induced phosphorylation of MEK1/2 in both parental and N1 cells, probably because the suppression of ERK phosphorylation by PD03 reduced negative feedback regulation, as reported previously ([@bib43]). Interestingly, activation of MEK1/2 and ERK1/2 by FGF2, a known activator of MEK-ERK signaling, was abrogated in N1 cells. We, therefore, examined whether NR5A1 overexpression decreased the expression of FGFR1, a major receptor for FGF2 ([@bib33]). FGFR1 was significantly downregulated at the mRNA and protein levels after NR5A1 overexpression, while the low levels of *FGFR2*, *3*, and *4* remained unchanged ([Figures S2](#mmc1){ref-type="supplementary-material"}K and S2L). These results suggest that decreased FGFR1 expression diminished the response to FGF2, suppressing MEK/ERK activation in N1 cells. Taken together, we can conclude that the pluripotent state induced by NR5A1 is independent of MEK-ERK signaling, making treatment with PD03 unnecessary. Therefore, we focused on investigating the characteristics of N1 cells cultured with CHIR.

As the self-renewal of primed hESCs is dependent on TGF-β/activin/nodal signaling ([@bib53]), we next cultured N1 cells with the activin receptor-like kinase inhibitors A83-01 (A83) and SB431542 (SB43). Their dependency on TGF-β/activin/nodal signaling became pronounced as the passage number increased ([Figure S3](#mmc1){ref-type="supplementary-material"}A), indicating that NR5A1-induced cells were dependent on these pathways.

In the primed state, hESCs maintain a glycolytic metabolic state with a low mitochondrial respiration capacity, which changes to a low glycolysis, highly aerobic respiration-dependent state in the naive state ([@bib15], [@bib42], [@bib44], [@bib57]). Therefore, we analyzed the metabolic state of N1-CHIR cells in comparison with parental cells, N1-DOX (−), and N1-DOX (+) (−) cells, which were transferred from the CHIR condition with DOX to the TF condition without DOX ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C). Although the basal oxygen consumption rate revealed minimal changes between the cell lines, maximal respiration was significantly increased in N1-CHIR cells compared with the other lines.

Previous reports have demonstrated a higher frequency of genomic instability in naive cells subjected to continuous passaging by single-cell dissociation ([@bib35], [@bib47]). In this study, while NR5A transfectants derived from H9 cells displayed normal karyotypes for \>10 passages, chromosomal abnormalities were observed at 25 and 19 passages in N1 cells derived from KhES-1 and 253G1 cells, respectively ([Figures S3](#mmc1){ref-type="supplementary-material"}D and S3E). This indicates that the risk of genomic instability increased by single-cell dissociation, even though the cells retained their pluripotent state.

NR5A1-Induced Cells Have Transcriptional Features of Both Primed and Naive Pluripotency {#sec2.3}
---------------------------------------------------------------------------------------

To examine the global transcriptional state of NR5A1-induced cells grown under the CHIR condition, we first performed microarray analysis of N1-CHIR cells, comparing them with parental cells cultured under TF or CHIR conditions (parental-TF and parental-CHIR cells, respectively) and N1 cells cultured under the TF condition (N1-TF cells; [Figures 3](#fig3){ref-type="fig"}A--3C). Principal-component analysis and heatmaps showed similar transcriptional states for N1 cells under both culture conditions, but these patterns were completely different from those of parental-TF or parental-CHIR cells ([Figures 3](#fig3){ref-type="fig"}A and 3B). However, a set of genes associated with naive pluripotency, including *ZFP57*, *FGF4*, *KHDC3L*, and *CTSF* was upregulated in N1-CHIR cells compared with N1-TF cells ([Figure 3](#fig3){ref-type="fig"}B; [Table S3](#mmc2){ref-type="supplementary-material"}), suggesting that the CHIR condition is more suitable for the promotion of naive-associated gene expression than the TF condition. CHIR treatment of parental cells induced a marked increase in the expression of gene sets associated with ectoderm differentiation and Wnt signaling ([Figures 3](#fig3){ref-type="fig"}C and [S4](#mmc1){ref-type="supplementary-material"}A), whereas upregulation of these genes was not observed in N1-CHIR cells, indicating that the response of NR5A1-induced cells to GSK3 blockade was altered at the transcriptional level. We next performed RNA sequencing (RNA-seq) analysis of parental-TF and N1-CHIR cells ([Figures 3](#fig3){ref-type="fig"}D--3I); comparative analysis of RNA-seq datasets from this study and of human naive-like cell lines ([@bib3], [@bib10], [@bib44], [@bib47]) indicated that N1-CHIR cells were closer to 3iL and NHSM cells than to 4i/L/A, 5i/L/A, WIBR3-DOX, or reset cells ([Figure 3](#fig3){ref-type="fig"}D; [Table S4](#mmc3){ref-type="supplementary-material"}). Among the naive-associated genes examined, *KLF2* and *KLF17* expression was lower in N1-CHIR cells than in 4i/L/A, 5i/L/A, WIBR3-DOX, or reset cells ([Figures 3](#fig3){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}B). Overexpression of NR5A1 markedly increased DNA methyltransferase 3 beta (DNMT3B) expression at the mRNA and protein levels ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C). We next examined the expression of transposable elements (TEs), such as human endogenous retroviruses (HERVs), HERV-associated long terminal repeats (LTRs), and SINE-VNTR-*Alu* (SVA) elements, as diminished transcription of LTR7 and HERVH-int elements and elevated transcription of LTR5_Hs, HERVK-int, and SVA elements was reported in 5i/L/A and reset cells ([@bib14], [@bib46]). LTR5_Hs and HERVK-int elements were listed in the top 100 TEs (log~2~ fold change \> 1.5, adjusted p \< 0.05; [Table S5](#mmc4){ref-type="supplementary-material"}). The heatmap revealed significantly increased expression of these transcripts in N1 cells ([Figures 3](#fig3){ref-type="fig"}F and 3G). However, while expression of some LTR7 and HERVH-int elements was reduced, a large number of elements showed increased expression ([Figures 3](#fig3){ref-type="fig"}H and 3I). SVA elements were low and unchanged between parental-TF and N1-CHIR cells ([Figure 4](#fig4){ref-type="fig"}D, right panel). These results demonstrate that NR5A1-induced cells have features of both primed and naive pluripotency, suggesting that they represent an intermediate state of conversion between these states.Figure 3NR5A1-Induced Cells Bear Transcriptional Features of Both Primed and Naive Pluripotency(A) Principal-component analysis (PCA) of microarray data from parental and N1 cells cultured under TF or CHIR conditions.(B and C) Heatmaps of genes selected from microarray data under each condition.(D) PCA of RNA-seq data from this study and previously published human naive-like cell lines (3iL, NHSM, WIBR2_4i/L/A, WIBR3_4i/L/A, WIN1_5i/L/A, and WIBR3_DOX, H9_reset), human primed cell lines (hESC_passage0 and 10), and human embryos.(E) Expression of individual genes in the RNA-seq data in (D). Values are shown as the log~10~ (RPKM+1). RPKM, reads per kilobase of exon per million mapped reads.(F--I) Heatmaps (adjusted p \< 0.05, log~2~ FC \> 1.5; F and H) and expression patterns (G and I) of selected TEs under each condition.All microarray and RNA-seq data in this study were obtained from three biological replicates. See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Tables S3](#mmc2){ref-type="supplementary-material"}, [S4](#mmc3){ref-type="supplementary-material"}, and [S5](#mmc4){ref-type="supplementary-material"}.Figure 4Induction of the Full Naive Pluripotent State in NR5A1-Induced Cells(A) Representative images of cells cultivated under TF, CHIR, and tt2iLGöX conditions. (N1) represents the absence of NR5A1 expression by DOX withdrawal. EOS-reset cells were established as a control for naive cells. Scale bar, 100 μm.(B) PCA of RNA-seq data from this study and previously published human naive-like cell lines (3iL, NHSM, WIBR2_4i/L/A, WIBR3_4i/L/A, WIN1_5i/L/A, and WIBR3_DOX, H9_reset), human primed cell lines (hESC_passage0 and 10), and human embryos.(C and D) Heatmaps of naive-associated genes (C) and TEs (D) FDR \< 0.05 among parental, N1, and EOS(N1) cells under each condition.(E) Transcriptional status of the two X chromosomes under each condition. A heatmap of X-linked genes and SNP-based allelic expression patterns in the RNA-seq data were analyzed. Allelic expression patterns of representative genes (blue box) are shown with their reference SNP IDs (rs), locations on the X chromosome (red bars), and type of expression ("monoallelic" or "biallelic"; gray box). RNA-seq data were obtained from one (EOS-TF, EOSN1-CHIR, and EOS-reset) and three (EOS(N1)-tt2iLGöX) biological samples.(F) Bisulfite sequencing analysis of DMRs in imprinted genes. Open and closed circles represent unmethylated and methylated CpG sites, respectively. See also [Figure S5](#mmc1){ref-type="supplementary-material"}, [Tables S4](#mmc3){ref-type="supplementary-material"} and [S6](#mmc5){ref-type="supplementary-material"}.

NR5A1-Induced Cells Can Progress to the Full Naive Pluripotent State without NR5A1 Overexpression {#sec2.4}
-------------------------------------------------------------------------------------------------

To examine whether NR5A1-induced cells exist in a state where they can be converted to naive pluripotency, we next investigated whether N1 cells can progress to the full naive state. Analyses of N1 cells revealed that 2i and 2i/LIF conditions had little effect on *DPPA3* expression and proliferation ([Figures 2](#fig2){ref-type="fig"}D and 2F), leading us to test a tt2iLGöX condition containing titrated CHIR, PD03, LIF, the protein kinase inhibitor Gö6983, and the tankyrase inhibitor XAV939, which was recently reported to be a more efficient protocol for naive induction ([@bib14]). Because naive induction under the tt2iLGöX condition is accompanied by differentiation and cell death ([@bib14]), the EOS-C(3+)-GFP-IRES-Puro (EOS-GFP) reporter system, which monitors the activity of a multimerized CR4 element derived from the mouse *Oct3/4* distal enhancer driven by an early transposon promoter ([@bib14], [@bib22], [@bib44]), was used to detect and purify naive cells. GFP expression in DOX-treated parental cells carrying EOS-GFP (EOS-TF cells) was lower than in cells with NR5A1 expression and CHIR treatment (referred to as EOSN1-CHIR cells; [Figures 4](#fig4){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}D). After switching from CHIR to tt2iLGöX medium, colonies cultured with DOX gradually collapsed and displayed slower proliferation ([Figure S4](#mmc1){ref-type="supplementary-material"}E), whereas DOX-untreated cells (referred to as EOS(N1)-tt2iLGöX cells) formed dome-shaped colonies with robust GFP expression ([Figures 4](#fig4){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}D). These results suggest that NR5A1 overexpression is dispensable upon conversion, as previously reported in mice ([@bib13]). We next performed RNA-seq analysis of EOS(N1)-tt2iLGöX cells for direct comparison with the reset cells ([@bib14]) as well as cells in formative pluripotency, which is an intermediate state of the conversion from naive to primed pluripotency ([@bib38]). The results demonstrated that EOS(N1)-tt2iLGöX cells shared features with reset cells in terms of both gene and TE expression ([Figures 4](#fig4){ref-type="fig"}B--4D; [Tables S4](#mmc3){ref-type="supplementary-material"} and [S6](#mmc5){ref-type="supplementary-material"}). Notably, N1 cells were clustered closely together with cells at days 7 and 10 of formative transition when expression of formative pluripotency-associated genes was compared ([@bib38]) ([Figure S4](#mmc1){ref-type="supplementary-material"}F). These findings suggest that NR5A1-induced cells are in an intermediate state between naive and primed states in terms of their gene expression profile and were converted to the full naive state. Moreover, the findings suggest that naive pluripotency can be induced from the intermediate cell state, which is stably maintained by NR5A1 overexpression and CHIR treatment.

X chromosome status is an important hallmark used to define the state of hPSCs ([@bib39], [@bib46]). We therefore investigated this in NR5A1-induced intermediate cells by RNA-fluorescence *in situ* hybridization (FISH) and SNP-based allelic expression analysis of X-linked genes using RNA-seq data. RNA-FISH of *XACT* and *HUWE1*, which are subjected to X chromosome reactivation ([@bib39]), and SNP analyses revealed eroded X inactivation (XaXe) of EOS-TF cells ([Figures 4](#fig4){ref-type="fig"}E, [S5](#mmc1){ref-type="supplementary-material"}A, and S5B), as reported previously ([@bib31]). In EOSN1-CHIR cells, no *XIST* coating was observed ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Almost all examined X-linked genes were biallelically expressed in the cells, although monoallelic expression of *HUWE1* was strongly enforced ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). This result is consistent with the increased transcriptional states of X-linked genes in EOSN1-CHIR cells compared with EOS-TF cells ([Figure 4](#fig4){ref-type="fig"}E). In tt2iLGöX medium, the proportion of cells expressing *HUWE1* biallelically was markedly increased with the appearance of monoallelic *XIST* coating, but the majority of cells bore no *XIST* clouds ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C), and expression of X-linked genes was decreased ([Figure 4](#fig4){ref-type="fig"}E). Similar phenotypes were observed in our reset cells ([Figures 4](#fig4){ref-type="fig"}E and [S5](#mmc1){ref-type="supplementary-material"}A--S5C) and in previously established reset cells ([@bib14], [@bib39]). These results suggest that both X chromosomes are highly activated in the NR5A1-induced intermediate cell state.

Because naive cells are hypomethylated at differentially methylated regions (DMRs) in their imprinted genes ([@bib46]), we performed bisulfite sequencing analysis to examine the methylation levels of the DMRs of *PEG10* and *SNURF*-*SNRPN* ([Figure 4](#fig4){ref-type="fig"}F). The DMRs of parental-TF cells were partially methylated, as previously demonstrated in hPSCs ([@bib26]). DNA methylation was maintained on the DMRs of EOSN1-CHIR cells but absent in EOS(N1)-tt2iLGöX cells. These results strongly suggest that hypomethylation of imprinted DMRs is not established at the intermediate cell state, probably because of the sustained high expression of DNMT3A and DNMT3B in N1 cells ([Figure S4](#mmc1){ref-type="supplementary-material"}C).

NR5A1 Binds Regions of *DPPA2* and *DPPA4* that Regulate the Expression of *TFCP2L1* and *FGF4* but Not *KLF4* {#sec2.5}
--------------------------------------------------------------------------------------------------------------

To investigate the epigenetic status of NR5A1-induced intermediate cells, the active histone mark histone 3 lysine 4 trimethylation (H3K4me3) and the repressive mark histone 3 lysine 27 trimethylation (H3K27me3) were analyzed by chromatin immunoprecipitation sequencing (ChIP-seq). A sharp H3K4me3 peak observed in parental cells at the transcription start site (TSS) was increased in N1-CHIR cells ([Figure 5](#fig5){ref-type="fig"}A). In contrast, H3K27me3 peaks upstream of the TSS to downstream of the transcriptional end site were decreased in these cells. Naive pluripotency genes, including *KLF2*, *KLF4*, and *TFCP2L1*, which harbored bivalent H3K4me3 and H3K27me3 marks in parental cells, exhibited a loss of H3K27me3 in the intermediate state ([Figure 5](#fig5){ref-type="fig"}B). However, a clear reduction in H3K27me3 was detected at the TSSs of only a few development-associated genes, such as *NKX2-5*, in N1-CHIR cells ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B), whose phenotypes are different from those of previously established naive cells ([@bib47]). This analysis also revealed that H3K4me3 signals were increased on transcriptionally activated HERVHs in NR5A1-induced intermediate cells ([Figures 5](#fig5){ref-type="fig"}C and 5D).Figure 5ChIP-Seq Analysis of Histone Modifications and NR5A1 in NR5A1-Induced Cells(A) Average ChIP-seq signals for H3K4me3 (top) and H3K27me3 (bottom) concentrated around transcription start sites (TSSs) in parental and N1 cells.(B) H3K4me3 and H3K27me3 signal distributions on individual genes.(C) Signal enrichment of H3K4me3 marks on moderately and highly active types of HERVHs, characterized based on their expression in primed hPSCs, parental, and N1 cells. FPM, fragments per million mapped fragments.(D) Distributions of H3K4me3 and H3K27me3 signals on the *ABHD1*2B gene in N1 cells.(E) NR5A1 consensus motif detected by the *de novo* motif discovery algorithm MEME.(F) NR5A1 signal distributions on the three types of HERVHs in N1 cells.(G) NR5A1 signal distribution on the *KLKB1* gene in N1 cells.(H) NR5A1 signal distribution on the *DPPA2* and *DPPA4* genes in N1 cells.(I) Knockdown of *DPPA2* and *DPPA4* in N1 cells. Data were analyzed by the comparative ΔCt method. Cells treated with non-targeted siRNA (siRNA control) were set to 1. Data are represented as mean ± SD of three biological replicates. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 (Student\'s t test). See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

In mice, the *Oct3/4*, *Nanog*, and *Klf2* genes are direct targets of NR5A2 during somatic cell reprograming into iPSCs ([@bib20]). To examine whether these genes are targets of NR5A1, we performed ChIP followed by deep sequencing. Motif analysis of NR5A1 revealed a previously reported consensus motif ([Figure 5](#fig5){ref-type="fig"}E) ([@bib30]). ChIP signals were distributed near the TSSs of some genes, such as *NPAS4* ([Figure S6](#mmc1){ref-type="supplementary-material"}C), which were reported previously in the human adrenal cortical carcinoma cell line H295R ([@bib5]) suggesting that NR5A1 binding to these genes is independent of cell type, and confirming the accuracy of our ChIP-seq analysis. The analysis also revealed strong NR5A1 binding to nearby HERVH regions that are activated in primed hPSCs ([@bib50]) ([Figures 5](#fig5){ref-type="fig"}F and 5G), suggesting that NR5A1 is involved in the transcriptional activation of HERVHs, resulting in the stall at the intermediate conversion state. Significant enrichments were not observed on the *OCT3/4*, *NANOG*, or *KLF2* genes, but were observed in regions of *DPPA2* and *DPPA4* ([Figure 5](#fig5){ref-type="fig"}H). As both genes are key reprogramming factors in mice ([@bib21]), we performed knockdowns using short interfering RNAs (siRNAs) against *DPPA2* and *DPPA4* to confirm that these genes were functional in the NR5A1-mediated pluripotent state ([Figures 5](#fig5){ref-type="fig"}I and [S6](#mmc1){ref-type="supplementary-material"}D). Gene expression analysis of N1 cells after knockdown of both genes revealed downregulation of naive-associated genes, such as *NANOG*, *TFCP2L1*, and *FGF4*, although *KLF4* expression was maintained. Furthermore, *PAX6* and *FOXF1* were upregulated. These results suggest that the pluripotent state of N1 cells shifts toward differentiation rather than reverting to the primed state, suggesting that DPPA2 and DPPA4 may be involved in the transcriptional regulation of a subset of naive-associated genes in the NR5A1-induced intermediate state between prime and naive pluripotency ([Figure 6](#fig6){ref-type="fig"}A).Figure 6Graphical Summary of This Study(A) Transcription factors induced by NR5A1 overexpression. Arrows and dotted arrows represent direct and indirect potential targets of the indicated genes, respectively.(B) Representative features of hPSCs in the primed, intermediate, and naive states observed in this study. Asterisks indicate results from previous studies.

Discussion {#sec3}
==========

Accumulating studies on human naive pluripotency have provided ample criteria for evaluating whether established cells are distinct from primed pluripotent cells ([@bib3], [@bib4], [@bib6], [@bib10], [@bib36], [@bib44], [@bib47], [@bib52], [@bib55]). Based on these criteria, we concluded that NR5A1-induced cells exist in an intermediate state between the primed and naive states ([Figure 6](#fig6){ref-type="fig"}B). These cells bear a subset of features of naive pluripotency, such as clonogenicity, GSK3 and MEK-ERK independence, increased mitochondrial respiration capacity, naive-specific gene and LTR5-HERVK expression profiles, and two activated X chromosomes. The results suggest that these phenotypic changes occur early in the process of naive conversion. Features, such as TGF-β/activin/nodal and FGF independence, naive-specific expression profiles of TEs, DNA demethylation of imprinted genes, and *XIST* coating of the active X chromosome were observed under the tt2iLGöX condition, suggesting that these features are acquired during later stages of conversion. In addition to these results, *KLF17* was expressed at low levels in N1-CHIR cells, but was upregulated after switching to the tt2iLGöX condition. Previous studies have revealed that KLF17 is detectable in cells in the later stages of naive conversion ([@bib25]), supporting our definition of the pluripotent state of the NR5A1-induced cells. Collectively, our results suggest that naive conversion progresses in a stepwise fashion.

NR5A1 is an orphan nuclear receptor belonging to the nuclear receptor superfamily. In mice, the protein plays central roles in endocrine organ development and steroidogenesis by regulating the transcription of steroidogenic enzyme and glycolytic genes ([@bib27], [@bib40]). Notably, *Nr5a1* is not expressed in the blastocyst ([@bib12], [@bib24], [@bib34]). Nevertheless, Nr5a1 can replace Oct3/4 as a reprogramming factor in the generation of iPSCs from somatic cells ([@bib20]). Furthermore, it can convert mEpiSCs to a naive pluripotent state ([@bib13]). These studies led us to investigate the ability of NR5A1 in inducing human naive pluripotency. Consistent with the previous report on Nr5a1 function in mEpiSCs, continuous NR5A1 expression was dispensable after completing the conversion process in humans. However, NR5A1 overexpression induced only a subset of naive-associated features in hPSCs. The cellular response to suppressed GSK3 and MEK-ERK signaling appears to differ between mice and humans, as extrinsic suppression by 2i is required to establish naive cells from mEpiSCs with Nr5a expression ([@bib13]), which is in contrast to our results. Exogenous expression of Nr5a1 enhances the initial expression of *Klf2*, suggesting that *Klf2* could be direct target of Nr5a1 in mEpiSCs ([@bib13]), but no significant binding of NR5A1 was detected on *KLF2* in hPSCs. More importantly, whether Nr5a1 is involved is the activation of murine ERVs remains unknown. Our results suggest that the ability of NR5A1 to induce naive pluripotency differs slightly in mice and humans, and careful examination will be necessary to understand its molecular functions in different species.

Overexpression of NANOG and KLF2 induces the naive state in hPSCs ([@bib44], [@bib47]), and overexpression of KLF4 accelerates naive conversion in the t2iLGö condition ([@bib28]). These reports prompted us to investigate whether *NANOG* and *KLF4* are potential targets of NR5A1, but ChIP-seq analysis showed no significant binding to these genes. However, we found that NR5A1 bound to *DPPA2* and *DPPA4*, whose expression was upregulated in NR5A1-induced cells. Knockdown of both genes indicated that a DPPA2/4-dependent pathway regulated the expression of naive-associated genes, such as *TFCP2L1* and *FGF4*, but not *KLF4*. In addition, the siRNA-mediated depletion of *DPPA2* and *DPPA4* increased the expression of differentiation-associated genes. These observations suggest that these genes play a vital role in maintaining the proper balance between pluripotency and differentiation in the NR5A1-induced state.

It was unexpected that overexpression of NR5A1 elicited a suppressed response to MEK-ERK signaling by extrinsic FGF2 stimuli in a cell-autonomous manner, as such a response has not been reported in humans or mice. In general, FGF-MEK-ERK signaling has diverse functions, including cell-cycle control ([@bib37]); thus, it is highly possible that in this study the suppressed FGF2 response led to reduced proliferation and G1-phase cell accumulation in NR5A1-induced cells. Inhibition of ERK phosphorylation by PD03 is required for naive conversion, although *FGFR1* expression is downregulated in reset and 5iLA cells ([@bib44], [@bib47]). Notably, expression of other *FGFRs*, including *FGFR3*, is upregulated in these cells, but remained low in N1 cells ([Figure S2](#mmc1){ref-type="supplementary-material"}K). MEK-ERK signaling can be activated through FGFR3 as well as FGFR1 ([@bib33]), which might explain the necessity for PD03 in the naive state. Direct binding of NR5A1 to *FGFR1* was not observed in our ChIP-seq analysis, suggesting that NR5A1 indirectly regulates *FGFR1* expression.

We expected that human NR5A2 would have a similar ability as NR5A1 because mouse Nr5a2 also induces the naive state of mEpiSCs ([@bib13]), and human NR5A2 can function as an iPSC reprogramming factor in humans ([@bib51]). However, despite high sequence similarity between the *NR5A* genes in their DNA-binding domains, NR5A2 only partially mimicked the effects of NR5A1. Primed hPSCs express NR5A2, but show lower expression of PRDM14, KLF4, and TFCP2L1, and unlike NR5A1, NR5A2 overexpression did not promote expression of these genes. These results suggest that NR5A2-specific molecular mechanisms exist in hPSCs.

In summary, NR5A1 has the ability to induce and maintain cells at an intermediate state of naive conversion that has until now been inaccessible for study. Our data suggest that the pluripotent state of N1 cells may be comparable with the state of formative pluripotency, warranting further investigations on the relationship between the NR5A1-induced state and formative transition. Using NR5A1 overexpression to induce the naive state will be advantageous in elucidating the processes that regulate the conversion between naive and primed pluripotency. We cannot exclude the possibility that the pluripotent state induced by NR5A1 does not reflect a particular stage of normal development, as *NR5A1* is not expressed in the human ICM or in primed or naive cells ([@bib54]). However, this model will nonetheless contribute to our understanding of the molecular mechanisms that regulate pluripotency in humans.

Experimental Procedures {#sec4}
=======================

To establish a DOX-inducible lentiviral system, the pLV-tTRKRAB and pLVCT-tTR-KRAB vectors were purchased from Addgene (plasmids 12249 and 11643, respectively). To construct the pLV-tTR-KRAB-IRES-Neomycin (Neo) vector, an IRES-Neo cassette was inserted into pLV-tTRKRAB. To construct the pLVCT-NR5A-IRES-Puromycin (Puro) and pLVCT-NR5A-IRES-Zeocin (Zeo) vectors, the backbone of pLVCT carrying the CAG promoter was used after removing the DNA fragment (EGFP-IRES-tTR-KRAB). IRES-Puro and IRES-Zeo cassettes were subcloned into the vectors. FLAG-tagged NR5A1 and NR5A2 were amplified by PCR and each inserted into pLVCT-IRES-Puro. The pLVCT-3×FLAG-tagged NR5A1-IRES-Puro vector was generated for ChIP with an anti-FLAG antibody. Primer sequences are listed in [Table S1](#mmc1){ref-type="supplementary-material"}.
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